Comparison of Patients’ Phenotypes, Guideline-Directed Recommendations Compliance and Rates of Cardiotoxicity between Caribbean and United States Cardio-oncology Programs
References
- Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. July 2016; 66(4): 271–89. DOI: 10.3322/caac.21349
- Armenian SH, Lacchetti C, Barac A, et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 10 March 2017; 35(8): 893–911.
- Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019; 144(8): 1941–53. DOI: 10.1002/ijc.31937
- Torre L, Bray F, Siegel R, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012: Global Cancer Statistics, 2012. CA Cancer J Clin. March 2015; 65(2): 87–108. DOI: 10.3322/caac.21262
- Collado D, Arias M, Díaz P. Prevalencia de hipertensión arterial y factores de riesgo cardiovasculares en República Dominicana (ENPREFAR- HAS 17). Archivos Dominicanos de Cardiología. 2017; 12–33.
- Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J – Cardiovasc Imaging. 1 October 2014; 15(10): 1063–93. DOI: 10.1093/ehjci/jeu192
- Lax J, Piñeiro D, Fanconi M. Consenso de diagnóstico, prevención y tratamiento de la cardiotoxicidad por tratamiento médico del cáncer. Rev Argen Cardiol. 2013; 81: 5–64. DOI: 10.7775/rac.es.v81.i6.3537
- Camejo N, Schiavone A, Díaz M, et al. Cardiotoxicidad inducida por Trastuzumab en pacientes uruguayas portadoras de cáncer de mama HER positivo. Arch Med Interna. 2015; 37(3): 107–11.
- Cairo Saéz G, Batista NE, Peñate FD, De la Torre AV. Evaluación cardíaca de pacientes con cáncer de mama tratadas con antraciclinas. Revi Cubana Cardiol Cir CV. 2017; 23: 1–9.
- Santos DA, Tettamanti ME, Chacón C, et al. Cardiotoxicity alerts during treatment with trastuzumab in breast cancer at four-year Follow-up. Rev Argent Cardiol. 2019; 87: 105–10.
- Makavos G, Ikonomidis I, Palios J, et al. Cardiac imaging in cardiotoxicity: a focus on clinical practice. Heart Fail Rev [Internet]. 2020 [cited 2020 May 4]; 10.
http://link.springer.com/10.1007/s10741-020-09952-w (assessed 4 May 2020). - Armenian SH, Xu L, Ky B, et al. Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study. J Clin Oncol. April 2016; 34(10): 1122–30. DOI: 10.1200/JCO.2015.64.0409
- Guglin M, Krischer J, Tamura R, et al. Randomized trial of Lisinopril versus Carvedilol to prevent trastuzumab cardiotoxicity in patients with breast cancer. J Am Coll Cardiol. 11 June 2019; 73(22): 2859–68. DOI: 10.1016/j.jacc.2019.03.495
- Gulati G, Heck SL, Ree AH, et al. Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol. Eur Heart J. 2016; 37(21): 1671–80. DOI: 10.1093/eurheartj/ehw022
- Avila MS, Ayub-Ferreira SM, de Barros Wanderley MR, et al. Carvedilol for prevention of chemotherapy-related cardiotoxicity: The CECCY Trial. J Am Coll Cardiol. 2018; 71(20): 2281–90. DOI: 10.1016/j.jacc.2018.02.049
- Ma Y, Bai F, Qin F, et al. Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials. BMC Pharmacol Toxicol. 25 April 2019; 20(1): 18. DOI: 10.1186/s40360-019-0298-6
- Tashakkor AY, Moghaddamjou A, Chen L, Cheung WY. Predicting the risk of cardiovascular comorbidities in adult cancer survivors. Curr Oncol. 4 July 2013; 20(5): 360. DOI: 10.3747/co.20.1470
- Pavo N, Raderer M, Hülsmann M, et al. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. Heart. 1 December 2015; 101(23): 1874–80. DOI: 10.1136/heartjnl-2015-307848
- Cardinale D, Iacopo F, Cipolla CM. Cardiotoxicity of Anthracyclines. Front Cardiovasc Med. 2020; 7: 26. DOI: 10.3389/fcvm.2020.00026
DOI: https://doi.org/10.5334/gh.1153 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jun 29, 2022
Accepted on: Aug 19, 2022
Published on: Sep 20, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2022 Pamela Piña, Amparo Taveras, Amir Khan, Justin Coyle, Victor Bueno, Nishit Shah, Luis Cuello, Santiago Collado, Ann Mauer, Sorin Danciu, Cesar J. Herrera, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.